美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Merus Labs International Inc

1.30

0.0000

成交量：- -

成交額：- -

市值：1.52億

市盈率：-16.25

高：1.30

開：1.30

低：1.30

收：1.30

52周最高：1.33

52周最低：0.7005

股本：1.17億

流通股本：9,731.00萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.0800

淨資產收益率：--

總資產收益率：--

市淨率：1.05

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Merus Labs International Inc

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.meruslabs.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Merus Labs International Inc.是根據加拿大英屬哥倫比亞省法律於1973年12月註冊成立，並於1997年12月根據加拿大的安大略省法律繼續運營。公司是一家從事收購和許可的祖傳品牌的處方藥品的專業製藥公司。梅魯斯的企業發展戰略是通過產品收購計劃來推動的，該計劃把收購良機應用在源產品收購候選產品上。這種方法允許梅魯斯跨越廣泛的治療類到源製藥產品，其可以用於不提供給其他參与者的收購目標，並建立多元化的戰略採購藥品。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MSLI/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"MSLI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSLI\",,,,,undefined,":{"symbol":"MSLI","market":"US","secType":"STK","nameCN":"Merus Labs International Inc","latestPrice":1.3,"timestamp":1515186000000,"preClose":1.3,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":97310000,"shares":117000000,"eps":-0.08,"marketStatus":"交易中","change":0,"latestTime":"03-03 14:18:46 EST","open":1.3,"high":1.3,"low":1.3,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.08,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1772571600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.3,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSLI\",,,,,undefined,":{"symbol":"MSLI","floatShares":97310000,"roa":"--","roe":"--","lyrEps":0,"shares":117000000,"dividePrice":0,"high":1.3,"amplitude":0,"preClose":1.3,"low":1.3,"week52Low":0.7005,"pbRate":"1.05","week52High":1.3327,"institutionHeld":0,"latestPrice":1.3,"eps":-0.08,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.08,"open":1.3,"prevYearClose":1.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSLI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-05-11","symbol":"MSLI","fiscalQuarterEnding":null,"expectedEps":-0.01,"name":null,"time":"","type":"earning","dateTimestamp":1494475200000,"reportTimeType":"","actualEps":-0.01},{"market":"US","date":"2017-02-14","symbol":"MSLI","fiscalQuarterEnding":null,"expectedEps":-0.01,"name":null,"time":"盤前","type":"earning","dateTimestamp":1487048400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-12-14","symbol":"MSLI","fiscalQuarterEnding":null,"expectedEps":0,"name":null,"time":"盤前","type":"earning","dateTimestamp":1481691600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-08-15","symbol":"MSLI","fiscalQuarterEnding":null,"expectedEps":0,"name":null,"time":"盤前","type":"earning","dateTimestamp":1471233600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-05-11","symbol":"MSLI","fiscalQuarterEnding":null,"expectedEps":-0.01,"name":null,"time":"","type":"earning","dateTimestamp":1462939200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSLI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MSLI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.meruslabs.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Merus Labs International Inc.是根據加拿大英屬哥倫比亞省法律於1973年12月註冊成立，並於1997年12月根據加拿大的安大略省法律繼續運營。公司是一家從事收購和許可的祖傳品牌的處方藥品的專業製藥公司。梅魯斯的企業發展戰略是通過產品收購計劃來推動的，該計劃把收購良機應用在源產品收購候選產品上。這種方法允許梅魯斯跨越廣泛的治療類到源製藥產品，其可以用於不提供給其他參与者的收購目標，並建立多元化的戰略採購藥品。","exchange":"NASDAQ","name":"Merus Labs International Inc","nameEN":"Merus Labs"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MSLI\",market:\"US\",,,undefined,":null}}